India · Delayed Price · Currency is INR Shilpa Medicare Statistics
Total Valuation
Shilpa Medicare has a market cap or net worth of INR 185.08 billion. The enterprise value is 191.24 billion.
| Market Cap | 185.08B |
| Enterprise Value | 191.24B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Sep 4, 2026 |
Share Statistics
| Current Share Class | 195.58M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +24.91% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 48.51% |
| Owned by Institutions (%) | 19.63% |
| Float | 95.77M |
Valuation Ratios
The trailing PE ratio is 69.54 and the forward PE ratio is 48.78.
| PE Ratio | 69.54 |
| Forward PE | 48.78 |
| PS Ratio | 9.91 |
| PB Ratio | 6.63 |
| P/TBV Ratio | 9.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 42.19 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 56.83 |
| EV / Sales | 10.25 |
| EV / EBITDA | 39.12 |
| EV / EBIT | 53.30 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.26 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.45 |
| Debt / FCF | n/a |
| Interest Coverage | 8.95 |
Financial Efficiency
Return on equity (ROE) is 12.80% and return on invested capital (ROIC) is 8.73%.
| Return on Equity (ROE) | 12.80% |
| Return on Assets (ROA) | 5.41% |
| Return on Invested Capital (ROIC) | 8.73% |
| Return on Capital Employed (ROCE) | 10.59% |
| Weighted Average Cost of Capital (WACC) | 6.24% |
| Revenue Per Employee | 14.86M |
| Profits Per Employee | 2.68M |
| Employee Count | 1,241 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, Shilpa Medicare has paid 504.60 million in taxes.
| Income Tax | 504.60M |
| Effective Tax Rate | 13.18% |
Stock Price Statistics
The stock price has increased by +147.17% in the last 52 weeks. The beta is 0.37, so Shilpa Medicare's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +147.17% |
| 50-Day Moving Average | 964.32 |
| 200-Day Moving Average | 608.86 |
| Relative Strength Index (RSI) | 51.28 |
| Average Volume (20 Days) | 870,487 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shilpa Medicare had revenue of INR 18.44 billion and earned 3.32 billion in profits. Earnings per share was 13.60.
| Revenue | 18.44B |
| Gross Profit | 11.83B |
| Operating Income | 3.31B |
| Pretax Income | 3.83B |
| Net Income | 3.32B |
| EBITDA | 4.58B |
| EBIT | 3.31B |
| Earnings Per Share (EPS) | 13.60 |
Balance Sheet
The company has 496.60 million in cash and 6.66 billion in debt, with a net cash position of -6.16 billion.
| Cash & Cash Equivalents | 496.60M |
| Total Debt | 6.66B |
| Net Cash | -6.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.58B |
| Book Value Per Share | 141.05 |
| Working Capital | 2.61B |
Cash Flow
In the last 12 months, operating cash flow was 4.33 billion and capital expenditures -4.69 billion, giving a free cash flow of -354.90 million.
| Operating Cash Flow | 4.33B |
| Capital Expenditures | -4.69B |
| Depreciation & Amortization | 1.28B |
| Net Borrowing | 724.90M |
| Free Cash Flow | -354.90M |
| FCF Per Share | n/a |
Margins
Gross margin is 64.16%, with operating and profit margins of 17.93% and 18.03%.
| Gross Margin | 64.16% |
| Operating Margin | 17.93% |
| Pretax Margin | 20.77% |
| Profit Margin | 18.03% |
| EBITDA Margin | 24.86% |
| EBIT Margin | 17.93% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.06%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 0.06% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.37% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -24.91% |
| Shareholder Yield | -24.85% |
| Earnings Yield | 1.44% |
| FCF Yield | -0.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Shilpa Medicare is 981.50, which is 3.79% higher than the current price. The consensus rating is "Buy".
| Price Target | 981.50 |
| Price Target Difference | 3.79% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 26.19% |
| EPS Growth Forecast (3Y) | 37.98% |
Stock Splits
The last stock split was on October 3, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Oct 3, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |